Dan Peng, Juan Li, Bomiao Qin, Anying Xiong, Qin Ran, Lingling Bai, Xiang He, Xiaolan Li, Lei Zhang, Madeeha Arooj, Guoping Li
{"title":"来自mmp14高巨噬细胞的外泌体miR-6990-5p通过Th17细胞分化促进过敏性肺炎纤维化。","authors":"Dan Peng, Juan Li, Bomiao Qin, Anying Xiong, Qin Ran, Lingling Bai, Xiang He, Xiaolan Li, Lei Zhang, Madeeha Arooj, Guoping Li","doi":"10.1002/eji.70048","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Th17 cells contribute to pulmonary fibrosis, but the mechanisms driving their differentiation remain unclear. Using single-cell RNA sequencing (scRNA-seq) and a decision tree model, we identify IL17A as a key marker in mice exposed to <i>Saccharopolyspora rectivirgula</i> antigen (SR-Ag). Trajectory and T cell receptor (TCR) analyses reveal IL17A⁺ CD4 T cells as terminally differentiated and clonally expanded. Blocking IL17A reduces SR-Ag–induced lung inflammation and fibrosis. Exosomal miR-6990-5p from MMP14-overexpressing macrophages promotes Th17 differentiation and fibroblast-to-myofibroblast transition (FMT) in vitro. It directly targets STAT1, as confirmed by luciferase assays. Co-immunoprecipitation (Co-IP) and docking analyses show STAT1 interacts with ROR-γt and RUNX1. STAT1 knockdown upregulates ROR-γt, IL17A, and RUNX1 in co-cultures with naïve CD4 T cells. In vivo, miR-6990-5p exacerbates fibrotic hypersensitivity pneumonitis (FHP) in SR-Ag-exposed mice. These findings indicate that miR-6990-5p induces Th17 cell differentiation through the STAT1/RUNX1/ROR-γt/IL17A pathway, contributing to FMT and fibrosis progression. This highlights miR-6990-5p as a potential therapeutic target for FHP.</p>\n </div>","PeriodicalId":165,"journal":{"name":"European Journal of Immunology","volume":"55 10","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Exosome miR-6990-5p from MMP14high Macrophage Promotes Fibrosis Through Th17 Cell Differentiation in Hypersensitivity Pneumonia\",\"authors\":\"Dan Peng, Juan Li, Bomiao Qin, Anying Xiong, Qin Ran, Lingling Bai, Xiang He, Xiaolan Li, Lei Zhang, Madeeha Arooj, Guoping Li\",\"doi\":\"10.1002/eji.70048\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n <p>Th17 cells contribute to pulmonary fibrosis, but the mechanisms driving their differentiation remain unclear. Using single-cell RNA sequencing (scRNA-seq) and a decision tree model, we identify IL17A as a key marker in mice exposed to <i>Saccharopolyspora rectivirgula</i> antigen (SR-Ag). Trajectory and T cell receptor (TCR) analyses reveal IL17A⁺ CD4 T cells as terminally differentiated and clonally expanded. Blocking IL17A reduces SR-Ag–induced lung inflammation and fibrosis. Exosomal miR-6990-5p from MMP14-overexpressing macrophages promotes Th17 differentiation and fibroblast-to-myofibroblast transition (FMT) in vitro. It directly targets STAT1, as confirmed by luciferase assays. Co-immunoprecipitation (Co-IP) and docking analyses show STAT1 interacts with ROR-γt and RUNX1. STAT1 knockdown upregulates ROR-γt, IL17A, and RUNX1 in co-cultures with naïve CD4 T cells. In vivo, miR-6990-5p exacerbates fibrotic hypersensitivity pneumonitis (FHP) in SR-Ag-exposed mice. These findings indicate that miR-6990-5p induces Th17 cell differentiation through the STAT1/RUNX1/ROR-γt/IL17A pathway, contributing to FMT and fibrosis progression. This highlights miR-6990-5p as a potential therapeutic target for FHP.</p>\\n </div>\",\"PeriodicalId\":165,\"journal\":{\"name\":\"European Journal of Immunology\",\"volume\":\"55 10\",\"pages\":\"\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-10-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/eji.70048\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Immunology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/eji.70048","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Exosome miR-6990-5p from MMP14high Macrophage Promotes Fibrosis Through Th17 Cell Differentiation in Hypersensitivity Pneumonia
Th17 cells contribute to pulmonary fibrosis, but the mechanisms driving their differentiation remain unclear. Using single-cell RNA sequencing (scRNA-seq) and a decision tree model, we identify IL17A as a key marker in mice exposed to Saccharopolyspora rectivirgula antigen (SR-Ag). Trajectory and T cell receptor (TCR) analyses reveal IL17A⁺ CD4 T cells as terminally differentiated and clonally expanded. Blocking IL17A reduces SR-Ag–induced lung inflammation and fibrosis. Exosomal miR-6990-5p from MMP14-overexpressing macrophages promotes Th17 differentiation and fibroblast-to-myofibroblast transition (FMT) in vitro. It directly targets STAT1, as confirmed by luciferase assays. Co-immunoprecipitation (Co-IP) and docking analyses show STAT1 interacts with ROR-γt and RUNX1. STAT1 knockdown upregulates ROR-γt, IL17A, and RUNX1 in co-cultures with naïve CD4 T cells. In vivo, miR-6990-5p exacerbates fibrotic hypersensitivity pneumonitis (FHP) in SR-Ag-exposed mice. These findings indicate that miR-6990-5p induces Th17 cell differentiation through the STAT1/RUNX1/ROR-γt/IL17A pathway, contributing to FMT and fibrosis progression. This highlights miR-6990-5p as a potential therapeutic target for FHP.
期刊介绍:
The European Journal of Immunology (EJI) is an official journal of EFIS. Established in 1971, EJI continues to serve the needs of the global immunology community covering basic, translational and clinical research, ranging from adaptive and innate immunity through to vaccines and immunotherapy, cancer, autoimmunity, allergy and more. Mechanistic insights and thought-provoking immunological findings are of interest, as are studies using the latest omics technologies. We offer fast track review for competitive situations, including recently scooped papers, format free submission, transparent and fair peer review and more as detailed in our policies.